Syneos Health Inc - Ordinary Shares - Class A

NASDAQ:SYNH   3:08:53 PM EDT
93.77
+0.03 (+0.03%)
Products, Other Pre-Announcement

Novan Announces Strategic Priorities And Outlines Key Milestones

Published: 09/09/2021 12:16 GMT
Syneos Health Inc - Ordinary Shares - Class A (SYNH) - Novan Announces Strategic Priorities and Outlines Key Milestones.
Novan Inc - Planning for Three Potential New Drug Application (nda) Filings in Three Years.
Novan Inc - First NDA Submission Expected in Q3 2022 for Lead Program Sb206 in Molluscum Contagiosum.
Novan Inc - Sb019 Sars-cov-2 Development Program Advancing Toward Phase 1 Study in Healthy Volunteers, Targeted for 1h 2022.